Vestal Point Capital, LP: APOGEE THERAPEUTICS INC (APGE): Quarterly 13F Position History
As of Q1 2026, Vestal Point Capital, LP reported 1,100,000 shares of APOGEE THERAPEUTICS INC (APGE), worth $92.6M and representing 2.6% of its 13F equity book. Quarter-over-quarter share count change: + 550,000 (+100.0%) . The position first appeared in Q3 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.
- 1,100,000Shares Held (Latest Filing)
- $92.6MReported Market Value (Latest Filing)
- 2.6%Portfolio Weight (% of 13F Equity Book)
- +550,000Quarter-over-Quarter Share Change
- +$51.1MQuarter-over-Quarter Value Change
- 1,100,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,100,000 | +550,000 | +100.0% | $92.6M | 2.6% | $84.2 |
| Q4 2025 | 550,000 | +125,000 | +29.4% | $41.5M | 1.5% | $75.5 |
| Q3 2025 | 425,000 | +425,000 | — | $16.9M | 0.8% | $39.7 |
| Q2 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2024 | 0 | 136,500 | -100.0% | $0 | 0.0% | — |
| Q3 2024 | 136,500 | — | — | $8.0M | 0.6% | $58.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Vestal Point Capital, LP first disclose a APGE position in 13F-HR filings?
Vestal Point Capital, LP first reported APOGEE THERAPEUTICS INC (APGE) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.
What was Vestal Point Capital, LP's most recent quarter-over-quarter share-count change in APGE?
Between Q4 2025 and Q1 2026, Vestal Point Capital, LP added 550,000 shares of APGE (+100.0%), bringing the total reported position to 1,100,000 shares at a market value of $92.6M.
Does the implied price-per-share represent Vestal Point Capital, LP's cost basis in APGE?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.